MX2009007235A - "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.". - Google Patents

"derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".

Info

Publication number
MX2009007235A
MX2009007235A MX2009007235A MX2009007235A MX2009007235A MX 2009007235 A MX2009007235 A MX 2009007235A MX 2009007235 A MX2009007235 A MX 2009007235A MX 2009007235 A MX2009007235 A MX 2009007235A MX 2009007235 A MX2009007235 A MX 2009007235A
Authority
MX
Mexico
Prior art keywords
milk
low
original
carbohydrate
original calcium
Prior art date
Application number
MX2009007235A
Other languages
English (en)
Inventor
Birgit Kjaelgaard Giwercman
Original Assignee
Bkg Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bkg Pharma Aps filed Critical Bkg Pharma Aps
Priority claimed from PCT/DK2007/000005 external-priority patent/WO2007076873A1/en
Publication of MX2009007235A publication Critical patent/MX2009007235A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se dirige a ciertos derivados de tioxanteno y derivados de fenotiazina que son adecuados para el uso como agentes anti-infecciosos, en particular, para el tratamiento de enfermedades infecciosas. La invención se refiere además a composiciones que comprenden los agentes anti-infecciosos.
MX2009007235A 2007-01-05 2007-01-05 "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.". MX2009007235A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/DK2007/000006 WO2008080398A1 (en) 2007-01-05 2007-01-05 Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
PCT/DK2007/000005 WO2007076873A1 (en) 2006-01-05 2007-01-05 Low-carbohydrate milk with original calcium

Publications (1)

Publication Number Publication Date
MX2009007235A true MX2009007235A (es) 2009-10-16

Family

ID=37914358

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007235A MX2009007235A (es) 2007-01-05 2007-01-05 "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".

Country Status (18)

Country Link
US (1) US20100113430A1 (es)
EP (2) EP2301545A1 (es)
JP (2) JP5399921B2 (es)
CN (1) CN101594869B (es)
AT (1) ATE510540T1 (es)
AU (1) AU2008203743B2 (es)
CA (1) CA2673809C (es)
CY (1) CY1111778T1 (es)
DK (1) DK2114406T3 (es)
EA (1) EA016886B1 (es)
ES (1) ES2367151T3 (es)
HK (1) HK1139309A1 (es)
HR (1) HRP20110607T1 (es)
MX (1) MX2009007235A (es)
NZ (1) NZ577821A (es)
PL (1) PL2114406T3 (es)
PT (1) PT2114406E (es)
WO (2) WO2008080398A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009007235A (es) * 2007-01-05 2009-10-16 Bkg Pharma Aps "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
CN103172591B (zh) * 2013-03-13 2014-07-30 陕西科技大学 含吩噻嗪基的Schiff碱类化合物及其制备方法和应用
CN103709122B (zh) * 2013-11-29 2016-05-25 四川大学 用于治疗的抗肿瘤和抗真菌化合物
RU2019101646A (ru) * 2016-06-23 2020-07-23 Биоимикс Аб Противоинфекционные гетероциклические соединения и варианты их применения
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (es) 1958-05-29
DE1210890B (de) 1960-03-07 1966-02-17 Smith & Kline & French Lab Verfahren zur Herstellung von Trifluormethyl-xanthen- oder thioxanthenderivaten
GB1453828A (en) * 1972-12-08 1976-10-27 Kefalas As Fluoro-substituted thiaxanthene derivatives
US4407800A (en) * 1981-11-02 1983-10-04 University Of Virginia Alumni Patents Foundation Protozoacidal activity of phenothiazines
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
US20020151543A1 (en) * 1998-05-28 2002-10-17 Sepracor Inc. Compositions and methods employing R (-) fluoxetine and other active ingredients
FR2813792B1 (fr) * 2000-09-12 2003-03-14 Inst Necker Moyens pour la regulation des defenses immunitaires
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
AU2002325192B2 (en) 2001-07-06 2008-05-22 Veloxis Pharmaceuticals, Inc. Controlled agglomeration
US20030229082A1 (en) * 2002-01-16 2003-12-11 The Regents Of The University Of California Inhibition of RNA function
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
US7429660B2 (en) * 2003-08-13 2008-09-30 Kudos Pharmaceuticals Limited ATM inhibitors
CN1976723B (zh) * 2004-04-30 2010-12-29 Bkg制药有限公司 制备治疗或预防感染性疾病的药物的用途
WO2006094207A2 (en) * 2005-03-03 2006-09-08 St. Jude Children's Research Hospital Substituted phenoxazines and acridones as inhibitors of akt
MX2009007235A (es) * 2007-01-05 2009-10-16 Bkg Pharma Aps "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases

Also Published As

Publication number Publication date
JP5399921B2 (ja) 2014-01-29
ATE510540T1 (de) 2011-06-15
JP2013173752A (ja) 2013-09-05
JP2010514814A (ja) 2010-05-06
CA2673809A1 (en) 2008-07-10
EP2114406A1 (en) 2009-11-11
CY1111778T1 (el) 2015-10-07
NZ577821A (en) 2012-07-27
EP2114406B1 (en) 2011-05-25
PT2114406E (pt) 2011-08-25
WO2008080408A1 (en) 2008-07-10
HK1139309A1 (en) 2010-09-17
US20100113430A1 (en) 2010-05-06
EA200970663A1 (ru) 2009-12-30
AU2008203743B2 (en) 2012-07-12
AU2008203743A1 (en) 2008-07-10
EA016886B1 (ru) 2012-08-30
WO2008080398A1 (en) 2008-07-10
CN101594869B (zh) 2013-08-07
HRP20110607T1 (hr) 2011-09-30
DK2114406T3 (da) 2011-09-12
EP2301545A1 (en) 2011-03-30
PL2114406T3 (pl) 2011-10-31
CN101594869A (zh) 2009-12-02
ES2367151T3 (es) 2011-10-28
CA2673809C (en) 2013-08-13

Similar Documents

Publication Publication Date Title
WO2007076873A8 (en) Low-carbohydrate milk with original calcium
EA021675B2 (ru) Способ получения не содержащего лактозу молока
MX2009007235A (es) "derivados de tioxanteno utiles para el tratamiento de enfermedades infecciosas.".
NZ580380A (en) Functional serum protein product for use in infant food and therapeutic compositions, and methods for the preparation thereof
FI20020907A0 (fi) Menetelmä laktoosittoman maitotuotteen valmistamiseksi
SG191089A1 (en) Compositions for separation methods
WO2013068653A3 (en) Method for producing a milk product
EA200970300A1 (ru) Способ и устройство для опреснения
EA200801252A1 (ru) Концентрат, полученный из молочного продукта, обогащенный природно встречающейся сиалиллактозой, и способ его получения
JP2013540447A5 (es)
ATE527215T1 (de) Verfahren zur rückgewinnung der bestandteile des abwassers einer olivenmühle durch membrantechnologie
RU2013124801A (ru) Молочный продукт и способ его получения
DE60210304D1 (de) Verfahren zur herstellung einer proteinhaltigen fraktion, mit beta-tgf in aktivierter form bereichert, sowie die so erhaltene fraktion und deren therapeutische verwendungen
BRPI0603380A (pt) método para preparar material de proteìna do soro de leite desflavorizado, e, produto alimentìcio contendo soro de leite
NZ585594A (en) Methods for casein production
EP1147712A3 (en) Method for producing milk calcium composition
EP1935479A3 (de) Hybridprozess zur Meerwasserentsalzung
NZ595764A (en) Whey or raw milk demineralisation and fractionation
ATE364322T1 (de) Verfahren zur herstellung eines beta- laktoglobulin-angereichertes molkenproteinkonzentrates und darauf basierender texturverstärker zur verwendung in milchprodukten
WO2008079031A3 (en) Dairy product and process
MX2022006060A (es) Sistema y metodo para filtrar bebidas.
CY1114336T1 (el) Γαλα χαμηλης περιεκτικοτητας σε υδατανθρακες με το αρχικο ασβεστιο
FR2845096B1 (fr) Procede de desacidification de boissons
DK1960418T3 (da) Fremgangsmåde til oprensning af vancomycin
MX2023012796A (es) Metodos para preparar un producto de yogur.

Legal Events

Date Code Title Description
FG Grant or registration